MedTrace Logo

Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.

NCT06291883 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2024-03-06

No results posted yet for this study

Summary

These studies offer valuable insights into the potential development of KGR as a novel herbal-based preventive and therapeutic strategy against COVID-19.

Conditions

  • Coronavirus Disease 2019
  • Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Interventions

COMBINATION_PRODUCT

Kang Guan Recipe (Treat)

Accurately weigh the Chinese medicinal herbs in the formula by weight, conduct the origin identification of the medicinal materials, and follow the scientific traditional Chinese medicine preparation process. After extraction, concentration, and granulation, package them in aluminum foil, with each package containing 6 grams of concentrated powder.

COMBINATION_PRODUCT

Kang Guan Recipe (Placebo)

Use 3% Kang Guan Recipe concentrated powder, mix evenly with starch, and package in aluminum foil, with each package containing 6 grams of concentrated powder.

Sponsors & Collaborators

  • Sheng-Teng Huang

    lead OTHER

Principal Investigators

  • Sheng-Teng Huang, MD PhD · China Medical University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-09
Primary Completion
2023-04-18
Completion
2024-02-08

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06291883 on ClinicalTrials.gov